Incorrect Supplementary Material
In the published article, there was an error in Supplementary Figure 1B. A Duplicate image was given in Wound healing assay images of 0h Cqn (10µM) and Utt-B (250nM). The correct material statement appears below. There is no change in the wordings of the manuscript.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2022.991401/full#supplementary-material
Summary
Keywords
autophagy, chloroquine, apoptosis, uttroside B, hepatocellular carcinoma, chemoprevention
Citation
Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N and Anto RJ (2022) Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma. Front. Oncol. 12:991401. doi: 10.3389/fonc.2022.991401
Received
11 July 2022
Accepted
09 August 2022
Published
25 August 2022
Volume
12 - 2022
Edited and reviewed by
Zhou Jiang, University of Texas MD Anderson Cancer Center, United States
Updates
Copyright
© 2022 Nath, Swetha, Vijayakurup, Thangarasu, Haritha, Shabna, Aiswarya, Rayginia, Keerthana, Kalimuthu, Sundaram, Lankalapalli, Pillai, Towner, Isakov and Anto.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ruby John Anto, rjanto@rgcb.res.in
‡These authors have contributed equally to this work
†Present address: Lekshmi R. Nath, Department of Pharmacognosy, Amrita School of Pharmacy, Amrita; Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, India; Vinod Vijayakurup, Department of Anatomy and Cell Biology, Cancer and Genetics Research Complex, University of Florida, Gainesville, FL, United States
This article was submitted to Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.